1 / 5
Pipmed Medical
Pipmed Medical
Indocyanine green (ICG) is a near-infrared fluorescent dye. Protein-bound ICG can be excited by external light with a wavelength range of 750 ~ 810 nm and emits near-infrared light with a wavelength of about 840nm. Its half-life in blood is about 3 ~ 5 minutes. After entering the blood and binding to protein, it is absorbed by liver cells, then enters the intestine through the biliary tract, and finally is excreted with feces.
This product represents the first indocyanine green injection in China to pass double consistency evaluations, featuring high purity, low impurity content, and optimized storage conditions, providing stable and reliable diagnosis and treatment options to the medical community.
Indications: Detection of choroidal neovascularization, macular lesions, intraocular tumors, and retinal vascular lesions; Intraoperative staining of capsule and internal limiting membrane.
Advantages: Provides clear choroidal vascular images for accurate diagnosis. In cataract and retinal surgery, fluorescent staining helps identify internal membranes accurately, reducing intraoperative complications.
Indications: Evaluation of liver reserve function, liver tumor image development, liver segment identification, and biliary tract development observation.
Advantages: Optimal method to evaluate liver reserve function due to rapidity and safety. Helps physicians identify liver structures clearly, improving surgical accuracy.
Indications: Accurate localization of tumors, image development of the lymphatic system, and assessment of blood supply.
Advantages: Enhances the visibility of target tissues during operation, making it intuitive to judge targets.
Our research and development scope includes high-end medical devices (fluorescence imaging series), fluorescence contrast agent drugs (ICG, targeted contrast agents), and core components (CMOS camera modules, endoscopes), providing a full-chain solution. These products are utilized in over 500 large hospitals.
Focusing on core technologies such as molecular fluorescence, Raman spectroscopy, AI, and computer-aided drug molecular design (CADD), our mission is to lead in molecular fluorescence technology through the synergy of medical devices and pharmaceuticals.
Recognized as a specialized "little giant" enterprise, the organization holds 131 core invention patents and 7 US invention patents. Strategic partnerships have been established with international leading companies in Germany and Japan, serving cooperative businesses in more than 10 overseas countries.
